1[7]Czaja AJ,Manns MP.The validity and importance of subtypes in autoimmune hepatitis:a point of view.Am J Gastroenterol, 1995,90:1206
2[8]Desment VJ,Gerber M,Hoofnaagle JH.Classification of chronic hepatitis:diagnosis,grading and staging. Hepatology ,1994,19:1513
3[9]Gregorio GV,Portrian B,Reid F,et al.Autoimmune hepatitis in childhood:a 20-year experience.Hepatology,1997,25:541
4[10]Alvarez F,Berg PA,Bianch FB,et al.International autoimmune hepatitis group report :review of criteria for diagnosis of autoimmunehepatitis. J Hepatol, 1999,31:929
5[11]Czaja A,Carpenter HA.Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci, 1996,41:305
6[1]Summerskill WHJ,Korman MG, Ammon HV, et al.Predisone for chronic active liver disease:dose titration,standard dose and combination with azathioprine compound.Gut,1975,16:876
7[2]McFarlane IG.The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis.Gut, 1998,42:599
8[3]Orth T,Gerken G ,Kellner R ,et al .Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.J Hepatol, 1997,26:37
9[4]Targan SR,Landers C ,VidrichA,et al.High titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology,1995,108:1159
10[5]Treichel U,McFarlane BM,Seki T,et al.Demographics of anti-asialogiycoprotein receptor autoantibodies in autoimmune hepatitis. Hepatology ,1994,107:799
